A surrogate-based approach for post-genomic partner identification
<p>Abstract</p> <p>Background</p> <p>Modern drug discovery is concerned with identification and validation of novel protein targets from among the 30,000 genes or more postulated to be present in the human genome. While protein-protein interactions may be central to man...
Main Authors: | Giordano Tony, Eder Paul S, Brissette Renee, Hsiao Ku-chuan, Pillutla Renuka C, Fletcher Paul W, Lennick Michael, Blume Arthur J, Goldstein Neil I |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2001-09-01
|
Series: | BMC Biotechnology |
Online Access: | http://www.biomedcentral.com/1472-6750/1/6 |
Similar Items
-
Peptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2
by: Lennick Michael, et al.
Published: (2003-01-01) -
Surrogate utility estimation by long-term partners and unfamiliar dyads
by: Richard J Tunney, et al.
Published: (2015-03-01) -
Inescapable Fibrosis: The Development of Desquamative Interstitial Pneumonia Post-Lung Transplantation Performed for a Patient with Idiopathic Pulmonary Fibrosis
by: Paul Lilburn, et al.
Published: (2023-01-01) -
Natural versus Surrogate Keys. Performance and Usability
by: Dragos-Paul POP
Published: (2011-06-01) -
Three pairs of surrogate redox partners comparison for Class I cytochrome P450 enzyme activity reconstitution
by: Xiaohui Liu, et al.
Published: (2022-08-01)